Skip to NavigationSkip to content

News

0
SPR Therapeutics gains FDA extended approval for pain management system
Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System (PNS)...
0
Australia’s TGA approves psychedelics to treat mental health conditions
Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions....
0
Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines
Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected to have a capacity of...
0
Boston Scientific fined $42m over patent infringement
A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay to TissueGen...
>> More News Stories

Features

Veeva la Vida: A Roundup of the R&D and Quality Summit 2022

Pharmafocus journalists Ana Ovey and Lina Adams made their way to Zurich for Veeva’s annual R&D and Quality Summit 2022. Here...

>> More Features
>> More News Stories